We updated the design of this site on December 18, 2017. Learn more.
ClinicalTrials.gov Menu

Raltegravir + Lopinavir/Ritonavir Versus Efavirenz + Tenofovir + Emtricitabine in Treatment Naive Patients

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00752856
Recruitment Status : Completed
First Posted : September 16, 2008
Last Update Posted : April 2, 2014
California HIV/AIDS Research Program
Merck Sharp & Dohme Corp.
Information provided by (Responsible Party):
California Collaborative Treatment Group